What IP owners need to know.
The rise of personalised medicine brings IP challenges in
patenting, trade marks, data protection and more. Here's what
IP owners need to know.
Personalised medicine – or precision medicine –
customises therapies for individual patients based on their genetic
makeup, lifestyle and environment.
Treatment often focuses on targeting specific molecules or
pathways affecting a patient's disease. This approach is a
significant departure from the traditional one-size-fits-all model
of drug development.
More than 300 personalised medicines are currently available in
the US market, with roughly 47% targeting rare diseases, 40%
addressing cancer and 13% covering other conditions. Nine of the
top 10 most expensive personalised medicines are gene therapies
targeting the root cause of disorders, rather than just managing
symptoms.
